Live feed
Filing
SC 13D
SC 13D0001104659-16-154481·CRISPR Therapeutics AG
Schedule 13D ownership disclosure
PHASERX, INC.
Security class unavailable · CUSIP: 71723F103
Event date: 2016-10-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,104,045
- Percent of class
- 10.4200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-154481
- Form type
- SC 13D
- Filer
- CRISPR Therapeutics AG
- CIK
- CIK 1674416
- Filed
- Nov 03, 2016
- Reporting period
- Oct 24, 2016
- Description
- Schedule 13D beneficial ownership